Your session is about to expire
← Back to Search
Back2Play App for Concussion Recovery in Youth (Back2PlayApp Trial)
N/A
Waitlist Available
Led By Carol A DeMatteo, MSc
Research Sponsored by McMaster University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up surveyed 3 months after completion of study (6 months maximum from enrollment)
Awards & highlights
No Placebo-Only Group
Summary
This trial will evaluate if an App can help youths recover from concussion faster and reduce risk of reinjury.
Who is the study for?
This trial is for children and youth who have been diagnosed with a concussion, are currently experiencing symptoms, and are within 4 weeks of their diagnosis. It's not suitable for those with multiple injuries, developmental delays, or severe brain injury that needed resuscitation or surgery.
What is being tested?
The study tests the Back2Play App designed to help young people recover from concussions by following established guidelines. The app aims to prevent re-injury and reduce symptom severity during recovery lasting up to 3-6 months post-concussion.
What are the potential side effects?
Since this intervention involves using an application rather than medication, traditional side effects aren't expected. However, there may be indirect effects related to the management of concussion recovery.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ surveyed 3 months after completion of study (6 months maximum from enrollment)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~surveyed 3 months after completion of study (6 months maximum from enrollment)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in number and severity of Post-concussive symptoms (PCSS)
Rate of re-injury
Secondary study objectives
System Usability Scale (SUS) (for the App group only)
Time to recovery from concussion
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: App groupExperimental Treatment1 Intervention
Participants will use the Back2Play App to support them in following the guidelines for recovery from concussion
Group II: Usual CareActive Control1 Intervention
Participants will receive usual care which often means they are provided concussion recovery guidelines in handout format and receive whatever follow up is deemed necessary by treating physician
Find a Location
Who is running the clinical trial?
Hamilton-Wentworth Catholic District School BoardUNKNOWN
1 Previous Clinical Trials
362 Total Patients Enrolled
McMaster Children's HospitalOTHER
40 Previous Clinical Trials
18,794 Total Patients Enrolled
Montreal Children's Hospital of the MUHCOTHER
30 Previous Clinical Trials
116,430 Total Patients Enrolled
Natural Sciences and Engineering Research Council, CanadaOTHER
62 Previous Clinical Trials
3,101 Total Patients Enrolled
McMaster UniversityLead Sponsor
917 Previous Clinical Trials
2,616,072 Total Patients Enrolled
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,392 Previous Clinical Trials
26,529,261 Total Patients Enrolled
Carol A DeMatteo, MScPrincipal InvestigatorMcMaster University FHS
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have had a serious brain injury that needed intensive care or surgery.I am experiencing symptoms from my condition.I have been diagnosed with a concussion.
Research Study Groups:
This trial has the following groups:- Group 1: App group
- Group 2: Usual Care
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.